Trial Profile
Effects of Levosimendan on Cellular Metabolic Alterations in Patients With Septic Shock: A Randomised Controlled Study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Feb 2020
Price :
$35
*
At a glance
- Drugs Levosimendan (Primary) ; Dobutamine
- Indications Septic shock
- Focus Pharmacodynamics
- 08 Feb 2018 Planned End Date changed from 1 Dec 2018 to 1 Feb 2018.
- 08 Feb 2018 Planned primary completion date changed from 1 Dec 2018 to 1 Feb 2018.
- 17 Nov 2016 New trial record